Gordan, Lucio
Chang, Melody
Lafeuille, Marie-Hélène
Romdhani, Hela
Paramasivam, Fuad
Maiese, Eric M.
McKay, Caroline
Funding for this research was provided by:
Janssen Scientific Affairs, LLC
Article History
Accepted: 29 December 2020
First Online: 9 February 2021
Declarations
:
: LG is president and managing physician at Florida Cancer Specialists & Research Institute, president of American Oncology Partners, and a board member of Community Oncology Alliance and Florida Society of Clinical Oncology (FLASCO). MC is director of pharmacy operations at Florida Cancer Specialists & Research Institute, director of pharmacy operations at American Oncology Network, pharmacist liaison at the board of directors of FLASCO, and member of the Oncology Pharmacy Education Network Advisory Committee of the Association of Community Cancer Centers. CM is a former employee of Janssen Scientific Affairs, LLC and may own stocks or stock options. EMM is a former employee of Janssen Scientific Affairs, LLC and may own stocks or stock options. MHL, HR, and FP are employees of Analysis Group, Inc., which provided paid consulting services to Janssen Scientific Affairs, LLC for the conduct of the present study.
: This work was supported by Janssen Scientific Affairs, LLC.
: Not applicable to this study.
: Not applicable to this study.
: Not applicable.
: The data used in this study are not publicly available.
: Not applicable.
: Partial results of this study were presented as a published research abstract at the 61st American Society of Hematology Annual Meeting & Exposition (2019).